TY - Generic T1 - GARNET: high SVR rates following eight-week treatment with ombitasvir/paritaprevir/ritonavir + dasabuvir for patients with HCV genotype 1b infection [abstract 163] T2 - New Perspectives in Hepatitis C Virus Infection - The Roadmap for Cure, September 23-24, 2016 Y1 - 2016 A1 - T M Welzel A1 - Stefan Zeuzem A1 - Dumas, EO. A1 - et, al AB -

Abstact 163

JA - New Perspectives in Hepatitis C Virus Infection - The Roadmap for Cure, September 23-24, 2016 CY - Paris, France ER -